Concepedia
Statistics
Publications
34
Citations
1.8K
H-Index
21
Active since
1985
Affiliations
Ionis Pharmaceuticals (United States)(Current)
Eli Lilly (United States)
Duke Medical Center
The University of Texas Health Science Center at Houston
Altoona Center for Clinical Research
David Monteith is an author at Ionis Pharmaceuticals (United States) specializing in medicine, pharmacology, and toxicology.
Top concepts
MedicinePharmacologyToxicologyDrug DiscoveryPharmacotherapyImmunologyPhysiologyBiochemistryLiver PhysiologyClinical Chemistry
Publications per year
1985–2018
Hepatic and glucagon-like peptide-1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors
Kyle W. Sloop, Julia X.C. Cao, Angela M. Siesky et al. · Journal of Clinical Investigation · 2004 · 210 citations · Full text
Chemically Modified Oligonucleotides Exhibit Decreased Immune Stimulation in Mice
Scott P. Henry, Kim Stecker, Doug A. Brooks et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 146 citations
In Vivo Distribution and Metabolism of a Phosphorothioate Oligonucleotide within Rat Liver after Intravenous Administration
Mark Graham, Stanley T. Crooke, David Monteith et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 139 citations
Tissue Disposition of 2′‐O‐(2‐methoxy) ethyl Modified Antisense Oligonucleotides in Monkeys
Rosie Z. Yu, Richard S. Geary, David Monteith et al. · Journal of Pharmaceutical Sciences · 2003 · 104 citations
Tissue Disposition, Medicine, Oligonucleotide +4
Characterization of Oligonucleotide MetabolismIn Vivovia Liquid Chromatography/Electrospray Tandem Mass Spectrometry with a Quadrupole Ion Trap Mass Spectrometer
Richard H. Griffey, Michael J. Greig, Hans Gaus et al. · Journal of Mass Spectrometry · 1997 · 95 citations
1–5 of 34